CN110157749B - Method for synthesizing MK-7 by using bacillus subtilis group response regulation and control system - Google Patents

Method for synthesizing MK-7 by using bacillus subtilis group response regulation and control system Download PDF

Info

Publication number
CN110157749B
CN110157749B CN201910490611.1A CN201910490611A CN110157749B CN 110157749 B CN110157749 B CN 110157749B CN 201910490611 A CN201910490611 A CN 201910490611A CN 110157749 B CN110157749 B CN 110157749B
Authority
CN
China
Prior art keywords
gene
promoter
sequence
genebank
hbs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910490611.1A
Other languages
Chinese (zh)
Other versions
CN110157749A (en
Inventor
刘龙
崔世修
吕雪芹
李江华
堵国成
陈坚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201910490611.1A priority Critical patent/CN110157749B/en
Publication of CN110157749A publication Critical patent/CN110157749A/en
Application granted granted Critical
Publication of CN110157749B publication Critical patent/CN110157749B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/66Preparation of oxygen-containing organic compounds containing the quinoid structure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/13Protein-histidine kinases (2.7.13)
    • C12Y207/13003Histidine kinase (2.7.13.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a method for synthesizing MK-7 by using a bacillus subtilis group response regulation and control system, belonging to the field of genetic engineering. The invention carries out truncation mutation on the phosphokinase KinAAnd use of a constitutive promoter PvegExpression, enabling the cell to produce a spore signal in a nutrient rich medium. The Spo0A system which is regulated by the response of the Phr60-Rap60 population is obtained by applying the method, and the high-efficiency synthesis of MK-7 is realized by dynamically regulating the synthesis way of MK-7, without additional inducer, and the dynamic balance between the high-efficiency synthesis of a target product and the growth of cells is realized. The yields of MK-7 produced by shake flask fermentation of finally obtained Bacillus subtilis recombinant bacteria BS19 and BS20 are respectively as high as 170mg/L and 360mg/L, which are 17.89 times and 37.89 times of Bacillus subtilis 168.

Description

Method for synthesizing MK-7 by using bacillus subtilis group response regulation and control system
Technical Field
The invention relates to a method for synthesizing MK-7 by applying a bacillus subtilis group response regulation and control system, belonging to the field of genetic engineering.
Background
Heptaene menadione (MK-7) is an important fat-soluble vitamin, which is used as a cofactor of gamma-glutamate carboxylase and plays an important role in regulating calcium distribution, promoting skeletal development to reverse osteoporosis, protecting blood vessels, and preventing atherosclerosis and cardiovascular disease response. More attention has been paid to heptamenadione due to its better affinity for the human body and longer half-life.
Bacillus subtilis is commonly used in the production of food enzyme preparations and important nutritional chemicals, and its products are certified by the FDA as "produced regulated as safe" (GRAS) grade. Therefore, the construction of the recombinant bacillus subtilis by using a metabolic engineering means is an effective way for efficiently synthesizing MK-7. However, the MK-7 synthesis pathway is very complex, leading to a major precursor phosphoenolpyruvate PEP flowing to the TCA cycle, which limits chorismate synthesis, and in addition, isopentenyl pyrophosphate is also an important substance for cell wall synthesis, which inhibits cell growth if knocked out; the MEP pathway intermediates 1-hydroxy-2-methyl-2-butenyl 4-diphosphate (HMBPP) and dimethylallyl Diphosphate (DMAPP) are both cytotoxic. How to adjust the supply of metabolic flux of Bacillus subtilis and increase the synthesis of MK-7 is a problem worth in-depth discussion.
Professor of Hanai.T, Kyushu university adopts LuxR population response regulation and control system from Vibrio fischeri (Vibrio fischeri) to realize automatic switching of carbon flow from a central metabolic pathway to an isopropanol pathway in Escherichia coli. The group of professor prather. k, academy of science and technology of ma kenchu, utilized the Esa system from bacterial blight of maize (Pantoea stewartii) to integrate the binding site of EsaR into the promoter region of the e.coli phosphofructokinase (pfkA) gene, inhibiting the transcription of pfkA gene and increasing the yield of the product inositol by 5.5 times. However, these studies use heterogeneous group response systems for regulation, which increases the burden of cell metabolism and weakens the system stability, and if the cell's own group response system is used to dynamically regulate the metabolic network, no additional burden is imposed on the cell metabolism. There have been no studies using dynamic regulation of population response in the study of menatetrenone.
Disclosure of Invention
In order to solve the existing technical problems, the invention constructs a population response dynamic regulation system of Phr60-Rap60-Spo0A and transforms PspoiiaAnd PabrbThe promoter is used for obtaining a promoter library with different transcriptional activities under the control of Spo0A-P, and key genes of HepS/T, ispH, pyk and uppS in a heptanenaphthoquinone synthetic pathway are dynamically controlled by the obtained promoter, the yields of MK-7 produced by shake-flask fermentation of finally obtained Bacillus subtilis recombinant bacteria BS19 and BS20 are respectively as high as 170mg/L and 360mg/L which are respectively 17.89 times and 37.89 times of Bacillus subtilis168, the recombinant bacteria BS20 is fermented in a fermentation tank for 3 days, and the yield of MK-7 can reach 230 mg/L.
The first object of the present invention is to provide a method for synthesizing MK-7 using a Bacillus subtilis population response regulatory system, which comprises the following modification on the chromosome of Bacillus subtilis:
(1) carrying out truncation mutation on the gene of the histidine kinase KinA, carrying out constitutive expression, and knocking out the gene of the histidine kinase KinB;
(2) will contain PhagThe Rap60 gene of the promoter is integrated on a chromosome, and two copies of the expression frame of the signal molecule Phr60 are integrated on the chromosome at the downstream of the Rap60 gene;
(3) using PabrB(cs-1)The promoter replaces the promoters of the pyruvate kinase gene and the undecenyl pyrophosphate synthetase gene; the P isabrB(cs-1)The sequence of the promoter is shown in SEQ ID NO. 14.
In one embodiment, the genebank ID of the histidine kinase KinA in step (1) is 939230; the truncation mutation refers to the knocking out of A PAS-A region of A signal conduction part of A histidine kinase KinA gene, and the sequence of the knocked-out histidine kinase KinA gene kinA-deltA PAS-A is shown in SEQ ID NO. 9; the genebank ID of the histidine kinase KinB is 937167.
In one embodiment, said P in step (2)hagThe promoter sequence is shown as SEQ ID NO. 16; the genebank ID of the transcription factor Rap60 is 1115983; the sequence of the expression cassette of the signal molecule Phr60 is shown in SEQ ID NO. 17.
In one embodiment, the pyruvate kinase gene pyk in step (3) has genebank ID 936596; the genebank ID of the undecenyl pyrophosphate synthetase gene uppS is 939640.
In one embodiment, the Bacillus subtilis is Bacillus subtilis 168.
In one embodiment, the Bacillus subtilis is Bacillus subtilis 168P43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::ganA Pmena-menA::thrCPmenadanA, in Bacillus subtilis168On the basis of the promoter P43Natural promoters for replacing menF and menB genes; by PhbsThe promoter replaces the natural promoter of the menE gene; by containing P43The promoter entC gene replaces the dhbB gene; by PhbsThe promoter replaces the native promoter of the tkt gene; by containing P43Integrating the ppsA gene of the promoter into a bacillus subtilis chromosome, and knocking out the ptsG gene; will aroGfbrGenes and promoters PhbsIntegration into chromosome after fusion; by P43The promoter replaces the native promoter of the aroK gene; by PhbsThe promoter replaces the native promoter of the ispA gene; by P43The promoter replaces the native promoter of the hepS/T gene; mixing the kdpG gene with promoter PhbsIntegration into chromosome after fusion; by P43The promoter replaces the natural promoters of dxr gene, dxs gene and fni gene; the open reading frame of menA is integrated and expressed at ganA, thrC and dacA sites of the bacillus subtilis genome, and the finally obtained strain is named as BS 17.
In one embodiment, the genebank ID of the menF is 937190; the genebank ID of menB is 937195; the P ishbsThe sequence of the promoter is shown as SEQ ID NO. 5; the genbank ID of menE is 937132; the entC gene is derived from e.coli K12, genebank ID is 945511; the genebank ID of the dhbB is 936582; the genebank ID of the tkt gene is 937377; the ppsA is derived from E.coli K12, and the genebank ID of the ppsA is 946209; the genebank ID of the ptsG is 939255; the aroGfbrThe sequence of the gene is shown as SEQ ID NO. 6; the genebank ID of the aroA is 937853; the genebank ID of the aroK is 938343; the hepS/T, genebank ID is 938998; the genebank ID of the kdPG is 33073472; the genebank ID of dxr is 939636; the genebank ID of dxs is 938609; the genebank ID of the fni is 938985; the sequence of the menA open reading frame is shown as SEQ ID NO. 8; the genebank ID of ganA is 936313; the genebank ID of thrC is 936660; the genebank ID of dacA is 940000.
In one embodiment, the method further comprises using Pspoiia(cs-1,3)Promoter expression of heptameric dimerAllyl diphosphate synthase gene and 4-hydroxy-3-methylbut-2-enyl diphosphate reductase gene; the P isspoiia(cs-1,3)The sequence of the promoter is shown in SEQ ID NO. 12.
In one embodiment, the heptapoly (diallyl-diphosphate) synthase gene HepS/T has genebank ID of 938998; the genebank ID of the 4-hydroxy-3-methylbut-2-enyldiphosphate reductase gene ispH is 937900.
The second purpose of the invention is to provide a recombinant bacterium for producing heptaene menadione, which is characterized in that the chromosome of bacillus subtilis is modified as follows:
(1) carrying out truncation mutation on the gene of the histidine kinase KinA, carrying out constitutive expression, and knocking out the gene of the histidine kinase KinB;
(2) will contain PhagThe Rap60 gene of the promoter is integrated on a chromosome, and two copies of the expression frame of the signal molecule Phr60 are integrated on the chromosome at the downstream of the Rap60 gene;
(3) using PabrB(cs-1)The promoter replaces the promoters of the pyruvate kinase gene and the undecenyl pyrophosphate synthetase gene; the P isabrB(cs-1)The sequence of the promoter is shown in SEQ ID NO. 14.
In one embodiment, the recombinant bacterium is further modified on the basis of BS17 as follows: carrying out truncation mutation on the gene of the histidine kinase KinA and constitutive expression to knock out the gene of the histidine kinase KinB; will contain PhagThe Rap60 gene of the promoter is integrated on a chromosome, and two copies of the expression frame of the signal molecule Phr60 are integrated on the chromosome at the downstream of the Rap60 gene; finally constructing to obtain a strain Bacillus subtilis168, P43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::ganA Pmena-menA::thrC Pmena-menA::dacA Pveg-kinA-ΔPAS-AΔkinB Phag-Rap60(Pnative-Phr60)2Hag, which is named BS 18.
In one embodiment, the recombinant bacterium is further modified on the basis of BS18 as follows: using PabrB(cs-1)The promoter replaces the promoters of pyruvate kinase (pyk, genebank ID: 936596) gene and undecenyl pyrophosphate synthetase (uppS, genebank ID: 939640) gene to obtain strain Bacillus subtilis168, P43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroKPhbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::ganA Pmena-menA::thrC Pmena-menA::dacA Pveg-kinA-ΔPAS-AΔkinB Phag-Rap60(Pnative-Phr60)2::hagPabrB(cs-1)-pyk::pyk PabrB(cs-1) -uppS:: uppS, which is named BS 19.
In one embodiment, the recombinant bacterium is further modified on the basis of BS19 as follows: using Pspoiia(cs-1,3)The promoter expresses heptadiallyl diphosphate synthase (HepS/T, genebank ID: 938998) gene and 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (ispH, genebank ID: 937900) gene to finally obtain strain Bacillus subtilis168, P43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fniPmena-menA::ganA Pmena-menA::thrC Pmena-menA::dacA Pveg-kinA-ΔPAS-AΔkinB Phag-Rap60(Pnative-Phr60)2::hag PabrB(cs-1)-pyk::pyk PabrB(cs-1)-uppS::uppS Pspoiia(cs-1,3)-ispH::ispH Pspoiia(cs-1,3)HepS/T, which is named BS 20.
The third purpose of the invention is to provide a method for producing heptaene menadione, which is to use the recombinant bacterium for fermentation production.
The invention has the beneficial effects that:
(1) by truncation mutation of phosphokinase KinA and use of constitutive promoter PvegExpression, enabling the cell to produce a spore signal in a nutrient rich medium.
(2) The Spo0A system which is regulated by the response of the Phr60-Rap60 population is obtained by applying the method, and the high-efficiency synthesis of MK-7 is realized by dynamically regulating the MK-7 synthesis pathway.
(3) No extra inducer is needed, and the dynamic balance between the high-efficiency synthesis of the target product and the cell growth is realized.
(4) When the strain obtained by the invention is added with sucrose, the yield of MK-7 is obviously improved.
(5) The yields of MK-7 produced by shake flask fermentation of finally obtained Bacillus subtilis recombinant bacteria BS19 and BS20 are respectively 170mg/L and 360mg/L, which are 17.89 times and 37.89 times of Bacillus subtilis 168. And the recombinant strain BS20 is fermented in a fermentation tank for 3 days, and the yield of MK-7 can reach 230 mg/L.
Biological material
Bacillus subtilis168 of the present invention was purchased from American type culture Collection, and the accession number thereof was ATCC No. 27370.
TABLE 1 genotype of the strains
Figure BDA0002086871300000031
Figure BDA0002086871300000041
TABLE 2 sequence listing
Figure BDA0002086871300000042
Figure BDA0002086871300000051
Drawings
FIG. 1: phosphokinase KinA structural schematic diagram and truncation mutation.
FIG. 2: the influence of different ratios of the signal molecules Phr60-Rap60 on the Spo0A regulation capability; pspoiia-GFP: strain BS168-Pspoiia-GFP; rap 60: strain BS17-2-Rap 60-GFP; phr60-Rap 60: the strain BS17-2-Phr60-Rap 60-GFP; 2 Phr60-Rap 60: strain BS17-2- (Phr60) 2-Rap 60-GFP.
FIG. 3: the number of Spo0A binding sites and the change of the sequence of the Spo0A binding sites on the regulation and control ability of the promoter.
FIG. 4: effect of cell concentration on Spo0A regulatory ability.
FIG. 5: phr60-Rap60-Spo0A dynamically regulates the MK-7 synthetic pathway.
FIG. 6: the level of transcription of key genes.
FIG. 7: and (3) carrying out shake flask fermentation on the recombinant bacteria to produce MK-7.
FIG. 8: and fermenting in a recombinant bacterium fermentation tank to produce MK-7.
Detailed Description
Extraction and HPLC detection of MK-7: adding 4 times volume of isopropanol and n-hexane mixture (1:2V/V) into the fermentation liquid, vortex shaking for 30min, filtering to obtain extractive solution, and centrifuging at 8000r/min for 15 min. The supernatant was collected, whereupon MK-7 was dissolved in this phase, frozen in a freezer at-80 ℃ to remove the lipid crystals, the filtrate was collected and assayed for MK-7 content by HPLC.
MK-7 production by HPLC: using an Agilent ZORBAX eclipseXDB-C18 separation column (5 μm, 250X 4.6mm), the temperature was measured at 40 ℃ and the mobile phase was purified using methanol: dichloromethane (9:1, v/v), flow rate 1mL/min, detection wavelength 254nm, sample size 10 uL.
Example 1: construction of recombinant bacterium BS17
(1) Construction of recombinant bacterium BS1
By constitutive promoter P43Replacement of the native promoter of menF on the chromosome of bacillus subtilis to enhance menF isochorismate synthase (a)menF, genebank ID: 937190) expression of the gene. Using a marker-free genetic modification strategy, see the article (Yan, x., Yu, h. -j., Hong, q., Li, s.p.,2008.Cre/lox system and PCR-basedgenome engineering in Bacillus subtilis, appl Environ micro b.74,5556-5562), the specific construction procedure is as follows:
(a) cloning of genes
① Bacillus subtilis168 genome as template, and primer menFupFOR and menFupREV amplification to obtain upstream homology arm sequence menF of menF geneup(the sequence is shown as SEQ ID NO. 1).
② artificially synthesizing a lox71-zeo-lox66 box (the sequence is shown as SEQ ID NO. 2) containing bleomycin gene.
③ Bacillus subtilis168 genome as template, primer P43For and P43Rev amplification to obtain P43A promoter sequence (the sequence is shown as SEQ ID NO. 3).
And fourthly, amplifying by using a bacillus subtilis168 genome as a template and adopting primers menF.FOR and menF.REV to obtain a menF gene segment (the sequence is shown as SEQ ID NO. 4).
(b) Obtaining fusion fragments
Subjecting the four fragments obtained in step (a) to a reactionupLox71-zeo-lox66 box, P43Carrying out overlap extension PCR on the promoter sequence and the menF gene segment, wherein the PCR conditions are as follows: pre-denaturation at 98 ℃ for 5min, then denaturation at 98 ℃ for 10s and annealing at 55 ℃ for 5s and 72 ℃ for 2min, carrying out 30 cycles in total, cutting gel and recovering the segment with the correct size to obtain the fusion gene segment menFup-lox71-zeo-lox66-P43-menF。
(c) Homologous recombination
Transforming the fusion fragment obtained in the step (b) into a wild type strain Bacillus subtilis168 competent cell. Because the upstream sequence of the menF existing in the fusion fragment is homologous with the upstream sequence gene of the menF on the chromosome 168 of the bacillus subtilis, the menF gene existing in the fusion fragment is homologous with the menF gene on the chromosome 168 of the bacillus subtilis, and the bleomycin resistance genes zeo and P in the fusion fragment are homologous through homologous recombination43Promoter replacement of subtillisThe menF gene native promoter on chromosome 168 of bacillus sp. The method comprises the following specific steps:
electrically transforming the fusion fragment constructed in the step (b) into competent cells of the bacillus subtilis168, wherein the addition amount of the fusion fragment is 100-300ng, and the electrical transformation conditions are as follows: the voltage is 2.5kV, the electric shock time is 5ms, the mixture is revived at 37 ℃ for 5h and coated with a bleomycin resistant LB plate with the final concentration of 10 mu g/mL, and the mixture is subjected to anaerobic culture at 37 ℃ for 48 h. The positive bleomycin resistance is transformed successfully by bacillus subtilis.
② selecting single colony growing on the plate, performing colony PCR verification with primers BS1YZ. FOR and BS1YZ.REV, replacing, amplifying to obtain fragment with length of 1350 bp., and sequencing to obtain lox71-zeo-lox66-P43The fusion gene successfully replaces the menF gene natural promoter on the chromosome 168 of Bacillus subtilis. Finally knocking out the bleomycin resistance gene zeo through a Cre/lox recombination system, and obtaining a strain Bacillus subtilis168, P after verification is correct43menF, named BS 1.
TABLE 3 primer sequence Listing
Figure BDA0002086871300000061
(2) Construction of recombinant bacterium BS2
Based on the strain BS1 obtained in step (1), P was used in a similar manner to that of step (1)43The promoter replaces the natural promoter of the dihydroxynaphthalene formate synthetase (menB, genebank ID: 937195) gene on the chromosome of the Bacillus subtilis168, and the strain Bacillus subtilis168, P is obtained after the verification is correct43-menF P43menB, named BS 2.
(3) Construction of recombinant bacterium BS3
Based on the strain BS2 obtained in step (2), P was used in a similar manner to that of step (1)hbsThe promoter (the sequence is shown as SEQ ID NO. 5) replaces the natural promoter of the O-succinylbenzoic acid-CoA ligase (menE, genebank ID: 937132) gene in the Bacillus subtilis, and the strain Bacillus subtilis168, P is obtained after the verification is correct43-menF P43-menB PhbsmenE, which was named BS 3.
(4) Construction of recombinant bacterium BS4
On the basis of the strain BS3 obtained in step (3), a strain containing P43The isochorismate synthase (entC, genebank ID: 945511) gene of the promoter derived from E.coli K12 replaces the isochorismate (dhbB, genebank ID: 936582) gene on the chromosome of Bacillus subtilis. The specific construction process is as follows:
(a) obtaining fusion fragments
Respectively amplifying to obtain dhbB gene upstream homologous arm sequences by taking bacillus subtilis168 genome as a templateupdhbB downstream homology arm sequence dhbBdown、P43A promoter sequence; artificially synthesizing a lox71-zeo-lox66 box sequence (the sequence is shown as SEQ ID NO. 2); taking E.coli K12 genome as template, amplifying to obtain entC gene sequence, and then separating five segments dhbBupLox71-zeo-lox66 box, P43Promoter sequence, entC gene sequence, dhbBdownOverlapping extension PCR is carried out on the gene segment to obtain a fusion gene segment dhbBup-lox71-zeo-lox66-P43-entC-dhbBdown
(b) Homologous recombination
Transforming the fusion fragment obtained in the step (a) into a BS3 competent cell, knocking out a bleomycin resistance gene zeo in a strain through a Cre/lox recombination system to obtain a strain Bacillus subtilis168, P43-menF P43-menB Phbs-menE P43-entC Δ dhbB, which is named BS 4.
(5) Construction of recombinant bacterium BS5
Based on the strain BS4 obtained in step (4), P was used in a similar manner to that of step (1)hbsThe promoter replaces the natural promoter of the transketolase (tkt, genebank ID: 937377) gene on the Bacillus subtilis chromosome, and the strain Bacillus subtilis168, P is obtained after the verification is correct43-menF P43-menB Phbs-menE P43-entCΔdhbBPhbs-tkt, which is named BS 5.
(6) Construction of recombinant bacterium BS6
On the basis of the strain BS5 obtained in step (5), the strain contains P43The phosphoenolpyruvate synthase (ppsA, genebank ID: 946209) gene of the promoter derived from E.coli K12 was integrated between the gene of yjeA (genebank ID: 936440) and the gene of yjfA (genebank ID: 939830) on the chromosome of Bacillus subtilis, and the glucose phosphate transporter (ptsG, genebank ID: 939255) gene on the chromosome was knocked out. The specific construction process is as follows:
(a) obtaining fusion fragments
Taking E.coli K12 genome as a template, amplifying to obtain ppsA gene, taking Bacillus subtilis168 genome as a template, respectively amplifying to obtain yjeA gene, yjfA gene and P43A promoter sequence; artificially synthesizing a lox71-zeo-lox66 box sequence (the sequence is shown as SEQ ID NO. 2). Then five fragments, yjeA, lox71-zeo-lox66 box, P43The PCR was performed by overlap extension of ppsA and yjfA to obtain the fusion gene fragment yjeA-lox71-zeo-lox66-P43-ppsA-yjfA。
Respectively amplifying ptsG upstream homology arms ptsG by using genome of bacillus subtilis168 as templateupAnd downstream homology arm ptsGdownTo ptsGup、lox71-zeo-lox66、ptsGdownPerforming overlap extension PCR to obtain fusion gene fragment ptsGup-lox71-zeo-lox66-ptsGdown
(b) Homologous recombination
Fusing the fusion fragment yjeA-lox71-zeo-lox66-P obtained in the step (a)43-ppsA-yjfA and ptsGup-lox71-zeo-lox66-ptsGdownAll are transformed into BS5 competent cells, then a bleomycin resistance gene zeo in a strain is knocked out through a Cre/lox recombination system, and the strain Bacillus subtilis 168P is obtained after verification is correct43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43ppsA. DELTA. ptsG, which was named BS 6.
(7) Construction of recombinant bacterium BS7
Artificially synthesized aroG is added on the basis of the strain BS6 obtained in the step (6)fbrGene (sequence shown in SEQ ID NO. 6) and promoterSeed Phbs(the sequence is shown as SEQ ID NO. 5) is fused and integrated between a stress protein (ytxj, genebank ID: 937308) gene and a 3-deoxy-D-arabinose-heptasulfonate 7-phosphate synthetase enzyme (aroA, genebank ID: 937853) gene on a bacillus subtilis chromosome, and the specific construction process is as follows:
(a) obtaining fusion fragments
Artificially synthesized aroGfbrGene (sequence shown in SEQ ID NO. 6); respectively amplifying ytxj gene, aroA gene and P by using Bacillus subtilis168 genome as templatehbsA promoter sequence. Then five fragments ytxj, lox71-zeo-lox66, Phbs、aroGfbrPerforming overlap extension PCR on aroA to obtain a fusion gene fragment ytxj-lox71-zeo-lox66-Phbs-aroGfbr-aroA。
(b) Homologous recombination
Transforming the fusion fragment obtained in the step (a) into a BS6 competent cell, knocking out a bleomycin resistance gene zeo in a strain through a Cre/lox recombination system, and obtaining a strain Bacillus subtilis 168P after verification is correct43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrIt is named BS 7.
(8) Construction of recombinant bacterium BS8
On the basis of the strain BS7 obtained in step (7), P was used in a similar manner to that in step (1)43The promoter replaces the natural promoter of shikimate kinase (aroK, genebank ID: 938343) gene on the Bacillus subtilis chromosome, and the strain Bacillus subtilis 168P is obtained after the verification is correct43-menF P43-menB Phbs-menE P43-entCΔdhbBPhbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43aroK, named BS 8.
(9) Construction of recombinant bacterium BS9
On the basis of the strain BS8 obtained in step (8), P was used in a similar manner to that of step (1)hbsPromoter replacement of farnesyl on Bacillus subtilis chromosomeThe natural promoter of the diphosphonate synthase (ispA, genebank ID: 938652) gene is verified to be correct to obtain the strain Bacillus subtilis 168P43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK PhbsispA, which was named BS 9.
(10) Construction of recombinant bacterium BS10
On the basis of the strain BS9 obtained in step (9), P was used in a similar manner to that in step (1)43The promoter replaces the natural promoter of heptadiallyl diphosphate synthase (hepS/T, genebank ID: 938998) gene on the Bacillus subtilis chromosome, and the strain Bacillus subtilis 168P is obtained after verification43-menF P43-menB Phbs-menEP43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK Phbs-ispA P43-hepS/T, named BS 10.
(11) Construction of recombinant bacterium BS11
On the basis of the strain BS10 obtained in the step (10), 2-dehydro-3-deoxy-phosphogluconate aldolase (kdpG, genebank ID: 33073472) gene derived from Zymomonas mobilis (Zymomonas mobilis) and promoter PhbsAfter fusion, the gene is integrated between urokinase (yclG, genebank ID: 938292) gene and spore germination response protein (gerkA, genebank ID: 938285) gene on the chromosome of the bacillus subtilis, and the specific construction process is as follows:
(a) obtaining fusion fragments
Synthesizing a kdpG gene by using a Zymomonas mobilis (Zymomonas mobilis) genome as a template; respectively amplifying to obtain yclG gene and P gene by using Bacillus subtilis168 genome as templatehbsA promoter sequence and a gerkA gene; artificially synthesizing a lox71-zeo-lox66 box sequence (the sequence is shown as SEQ ID NO. 2). The five fragments yclG, lox71-zeo-lox66 box, P were then insertedhbsOverlapping extension PCR is carried out on the promoter sequence, the kdpG and the gerkA to obtain a fusion gene fragment yclG-lox71-zeo-lox66-Phbs-kdpG-gerkA
(b) Homologous recombination
Transforming the fusion fragment obtained in the step (a) into a BS10 competent cell, knocking out a bleomycin resistance gene zeo in a strain through a Cre/lox recombination system, and obtaining a strain Bacillus subtilis 168P after verification is correct43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbr::lox72P43-aroK Phbs-ispA P43-hepS/T PhbskdpG, named BS 11.
(12) Construction of recombinant bacterium BS12
On the basis of the strain BS11 obtained in step (11), P was used in a similar manner to that in step (1)43The promoter replaces the natural promoter of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (dxr, genebank ID: 939636) gene on Bacillus subtilis chromosome, and strain Bacillus subtilis 168P is obtained after verification is correct43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43Dxr, which is named BS 12.
(13) Construction of recombinant bacterium BS13
On the basis of the strain BS12 obtained in step (12), P was used in a similar manner to that of step (1)43The promoter replaces the natural promoter of the 1-deoxyxylulose-5-phosphate synthase (dxs, genebank ID: 938609) gene in the Bacillus subtilis168, and the strain Bacillus subtilis 168P is obtained after the verification is correct43-menF P43-menB Phbs-menEP43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK Phbs-ispA P43-hepS/TPhbs-kdpG P43-dxr P43Dxs, which is named BS 13.
(14) Construction of recombinant bacterium BS14
In the step of(13) Based on the obtained strain BS13, P was used in a similar manner to that in step (1)43The promoter replaces the natural promoter of the gene in isopentenyl pyrophosphate isomerase (fni, genebank ID: 938985) on the Bacillus subtilis chromosome, and the strain Bacillus subtilis 168P is obtained after the verification is correct43-menF P43-menB Phbs-menEP43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK Phbs-ispA P43-hepS/TPhbs-kdpG P43-dxr P43-dxs P43Fni, named BS 14.
(15) Construction of recombinant bacterium BS15
Inserting menA reading frame into ganA site of Bacillus subtilis genome based on the strain BS14 obtained in step (14). ganA (genebank ID: 936313) expresses arabinogalactan type I oligomer exohydrolases. The specific construction process is as follows:
(a) cloning of genes
① the upstream homologous arm sequence ganA of ganA gene is obtained by using Bacillus subtilis168 genome as template and adopting primers mena-up and mena-upup
② artificially synthesizing a lox71-zeo-lox66 box (the sequence is shown as SEQ ID NO. 2) containing bleomycin gene.
③ using Bacillus subtilis168 genome as template, amplifying open reading frame of 1, 4-dihydroxy-2-naphthoic acid heptapentenyl transferase (menA) by using primers menA-orf.FOR and menA-orf.REV, detecting the amplified gene fragment with agarose gel to 1537bp, cutting the gel and recovering the fragment with correct size to obtain the nAme reading frame sequence P with nucleotide sequence as SEQ ID NO.8mena-menA。
④ the downstream homologous arm sequence ganA of ganA gene is obtained by taking Bacillus subtilis168 genome as a template and adopting primers menA-down and menA-downdown
(b) Obtaining fusion fragments
Subjecting the four pieces obtained in step (a) toSegment ganAupLox71-zeo-lox66 box, Pmena-menA、ganAdownThe gene segment is subjected to overlap extension PCR to obtain a fusion gene segment ganAup-lox71-zeo-lox66-Pmena-menA-ganAdown
(c) Homologous recombination
Transforming the fusion fragment obtained in the step (b) into BS14 competent cells, coating the competent cells on a bleomycin-resistant LB plate, selecting single colonies growing on the plate, carrying out colony PCR verification and sequencing. Finally knocking out the bleomycin resistance gene zeo in the strain through a Cre/lox recombination system to finally obtain the strain Bacillus subtilis 168P43-menFP43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbr::lox72P43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni PmenaganA, which is named as BS 15.
TABLE 4 primer sequence Listing
Figure BDA0002086871300000091
(16) Construction of recombinant bacterium BS16
On the basis of the strain BS15 obtained in step (15), the reading frame of menA is inserted into the thrC site of the Bacillus subtilis genome by a method similar to the step (15). thrC (genebank ID: 936660) translationally expresses threonine synthase. Obtaining a strain Bacillus subtilis 168P after verification43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbr::lox72P43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::ganA PmenathrC, which is named as BS 16.
(17) Construction of recombinant bacterium BS17
On the basis of the strain BS16 obtained in step (16), the insertion of the menA reading frame into the dacA site of the Bacillus subtilis genome was performed in a manner similar to that in step (15). dacA (genebank ID: 940000) expresses alanine carboxypeptidase. Obtaining a strain Bacillus subtilis 168P after verification43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbr::lox72P43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::ganA Pmena-menA::thrC PmenamenA, dacA, which is named BS 17.
Example 2: truncation mutation of histidine kinase KinA and expression using constitutive promoter
Histidine kinases, KinA and KinB, can phosphorylate themselves only under carbon starvation, then, DNA binding protein Spo0A is phosphorylated and activated, and phosphorylated Spo0A is bound with a promoter, so that the corresponding gene expression is up-regulated or down-regulated, and the ability of regulating the gene expression is exerted. However, efficient synthesis of the desired product requires a continuous supply of available carbon sources. Thus, KinA was obtained by truncating the histidine kinase and using the constitutive promoter PvegThe mutation method for expressing truncated phosphokinase KinA and truncated PAS-A domain as shown in FIG. 1 enables the continuous expression of histidine phosphokinase KinA.
(1) Obtaining fusion fragments
Respectively amplifying to obtain upstream homology arm sequence kinA of histidine kinase (kinA, genebank ID: 939230) by using Bacillus subtilis168 genome as templateupTruncated histidine kinase gene fragments kinA-deltA PAS-A (the sequence is shown as SEQ ID NO. 9) and PvegA promoter sequence (shown as SEQ ID NO. 10), artificially synthesizing a lox71-zeo-lox66 box sequence (shown as SEQ ID NO. 2), and then separating four fragments of kinAupLox71-zeo-lox66 box, PvegThe promoter sequence and the kinA-deltA PAS-A gene segment are subjected to overlap extension PCR to obtain A fusion gene segment kinAup-lox71-zeo-lox66-Pveg-kinA-ΔPAS-A。
② homologous recombination
Transforming the fusion fragment obtained in the step ① into the BS17 competent cell obtained in the example 1, coating the cell on a bleomycin resistant LB plate, selecting a single colony growing on the plate, carrying out colony PCR verification and sequencing, finally knocking out the bleomycin resistant gene zeo in the strain through a Cre/lox recombination system to obtain a strain Bacillus subtilis168, P43-menF P43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbr::lox72P43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::ganA Pmena-menA::thrC Pmena-menA::dacA Pveg-kinA- Δ PAS-A, named BS 17-1.
Example 3: knockout of histidine kinase KinB
In order to reduce the influence of other histidine phosphokinases on the regulatory system, another major phosphokinase KinB (kinB, genebank ID: 937167) was knocked out to ensure the uniqueness of the regulatory system. On the basis of the recombinant bacterium BS17-1 obtained in example 2, the phosphokinase gene kinB on the chromosome of Bacillus subtilis is knocked out.
(1) Obtaining fusion fragments
Respectively amplifying to obtain kinB by taking bacillus subtilis168 genome as a templateup、kinBdownArtificially synthesizing lox71-zeo-lox66 box sequence, and then dividing three fragments into kinBupLox71-zeo-lox66 box, kinBdownPerforming overlap extension PCR to obtain fusion gene fragment kinBup-lox71-zeo-lox66-kinBdown
② homologous recombination
Transforming the fusion fragment obtained in the step ① into a BS17-1 competent cell, coating the fusion fragment on a bleomycin-resistant LB plate, selecting a single colony growing on the plate, carrying out colony PCR verification and sequencing, and finally knocking out the bacterial strain by a Cre/lox recombination systemThe bleomycin resistance gene zeo finally obtains a strain Bacillus subtilis168, P43-menFP43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbr::lox72P43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::ganA Pmena-menA::thrC Pmena-menA::dacA Pveg-kinA- Δ PAS-A Δ kinB, which was named BS 17-2.
Example 4: construction of population response dynamic regulation system of Phr60-Rap60-Spo0A
The phosphorylation level of Spo0A is regulated by histidine kinase KinA, and in the strain BS17-2 obtained in example 3, KinA is subjected to truncation mutation and constitutive expression, and another main phosphokinase KinB is knocked out, so that Spo0A can be subjected to phosphorylation modification under the condition of rich nutrition, and thus the function is achieved. However, the Phr-Rap group response regulation and control system in the bacillus subtilis can only control the phosphorylation level of Spo0A-P, and cannot regulate the phosphorylation degree of KinA, so that KinA has phosphorylation capacity in the early stage of cell growth, which is not beneficial to dynamic regulation and synthesis of menatetrenone, and the solution is that the phosphorylation of KinA can be inhibited in the early stage of cell growth and can be released along with the growth of cells. It is reported that (DOI: 10.1111/mmi.12939) Phr60-Rap60 can inhibit not only the phosphorylation level of Spo0A, but also the phosphorylation level of KinA. Therefore, a Phr60-Rap60 population response system was introduced into the cells. And the proportion relation between the introduced Phr60 and Rap60 is determined through experiments, and the specific process is as follows:
(1) recombinant vector pHT01-PspoiiaConstruction of GFP
To verify the effect of Phr60-Rap60 on Spo0A-P phosphorylation, P regulated by Spo0A-P was usedspoiiaThe promoter is fused with Green Fluorescent Protein (GFP), and the regulation and control capacity of Spo0A-P is characterized through the change of the fluorescent value.
① primer PspoiiaFor and PspoiiaRev expansionPromoter Pspoiia(the sequence is shown as SEQ ID NO. 11), a green fluorescent protein GFP gene (the sequence is shown as SEQ ID NO.15) is obtained by utilizing primers GFP. for and GFP. rev amplification, the two fragments are connected to a pHT01 plasmid through a Gibson multi-fragment assembly technology, and finally, a recombinant vector pHT01-P is obtainedspoiia-GFP。
TABLE 5 primer sequence Listing
Figure BDA0002086871300000111
(2) On the basis of the recombinant strain BS17-2 obtained in example 3, a heterologous transcription factor Rap60(genebank ID: 1115983) was inserted into the chromosome of Bacillus subtilis.
Obtaining of fusion fragment
Respectively amplifying to obtain an upstream homologous arm sequence Rap60 of Rap60 gene by taking bacillus subtilis168 genome as a templateupRap60 gene fragment and PhagA promoter sequence (shown as SEQ ID NO. 16), artificially synthesizing a lox71-zeo-lox66 box sequence (shown as SEQ ID NO. 2), and then combining four fragments of Rap60upLox71-zeo-lox66 box, PhagOverlapping extension PCR is carried out on the promoter sequence and the Rap60 gene segment to obtain a fusion gene segment Rap60up-lox71-zeo-lox66-Phag-Rap60。
② homologous recombination
Transforming the fusion fragment obtained in the step ① into a BS17-2 competent cell, coating the fusion fragment on a bleomycin resistant LB plate, selecting a single colony growing on the plate, carrying out colony PCR verification and sequencing, knocking out a bleomycin resistant gene zeo in a strain through a Cre/lox recombination system, and finally obtaining a strain Bacillus subtilis168, P43-menFP43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbr::lox72P43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::lacA Pmena-menA::thrC Pmena-menA::dacA Pveg-kinA-ΔPAS-AΔkinB Phag-Rap60, named BS17-2-Rap 60.
(3) On the basis of the recombinant bacteria BS17-2-Rap60 obtained in the step (2), an expression box (shown as SEQ ID NO. 17) of a signal molecule Phr60 with one copy and two copies is not inserted, inserted and inserted into the downstream of a bacillus subtilis chromosome Rap60 gene, and the genebank ID of the Phr60 is 1115984, so that three bacteria BS17-2-Rap60, BS17-2-Phr60-Rap60, BS17-2- (Phr60) × 2-Rap60 are obtained.
(4) The recombinant plasmid pHT01-P constructed in the step (1)spoiiaRespectively transforming the wild type Bacillus subtilis168 and the three strains obtained in the step (3) by GFP to obtain four strains, which are respectively named as BS168-Pspoiia-GFP,BS17-2-Rap60-Pspoiia-GFP,BS17-2-Phr60-Rap60-Pspoiia-GFP,BS17-2-(Phr60)*2-Rap60-Pspoiia-GFP。
(5) Measurement of GFP fluorescence value
Culturing the 4 strains of bacteria constructed in the step (4) by using an LB culture medium, detecting the change of a fluorescent value by using a 96-well plate through a microplate reader every hour, wherein the fluorescent protein excitation wavelength is as follows: 395nm and the emission wavelength is 509 nm. As shown in FIG. 2, the fluorescence values of the strains expressing only Rap60 are very weak, indicating that Spo0A cannot activate promoter PspoiiaThe fluorescence intensity of the cells expressing two Phr60 is obviously higher than that of the cells expressing one copy, which shows that the higher the concentration of the signal molecule is, the higher the degree of activating Spo0A phosphorylation is, and the more the promoter expression can be activated. Therefore, the strain BS17-2- (Phr60) × 2-Rap60 is used as the starting strain of the next experiment and is named as BS18, the genotype of which is Bacillus subtilis168, P43-menF P43-menB Phbs-menEP43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK Phbs-ispA P43-hepS/TPhbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::ganA Pmena-menA::thrC Pmena-menA::dacAPveg-kinA-ΔPAS-AΔkinB Phag-Rap60(Pnative-Phr60)2Hag, used in the subsequent experiments.
Example 5: relationship between Spo0A-P regulatory gene expression and cell concentration
As the invention is based on the relation between the cell concentration and the gene expression intensity, in order to determine the influence of the cell concentration on Spo0A-P, the relation between the constructed population response Phr60-Rap60-Spo0A and the cell growth is detected, and P is used on pHT01 plasmidspoiiaAnd PabrbThe promoter expresses GFP protein, and recombinant plasmids pHT01-P are respectively constructedspoiiaGFP and pHT01-PabrbGFP, then the recombinant plasmid was transferred into the strain BS18 obtained in example 4, and the change in fluorescence value with cell growth was examined, as shown in FIG. 4, from which it can be seen that the transcription ability of the promoter was controlled by Spo0A-P when the cells grew to around 1.433.
Example 6: obtaining of mutant promoters
(1) Obtaining of Up-regulated promoters
In order to obtain a promoter with different regulatory abilities under the Phr60-Rap60, a promoter P up-regulated by Spo0A-Pspoiia(the sequence is shown as SEQ ID NO. 11) four Spo0A binding sites are respectively mutated to obtain 3 promoters P with different transcription capacitiesspoiia(cs-3)、Pspoiia(OA-3)、Pspoiia(cs-1,3)These promoters were fused to the GFP gene (sequence shown in SEQ ID NO.15), and the transcriptional capacities of the different promoters were characterized using the change in fluorescence.
The results show that: post-mutation Pspoiia(cs-1,3)The transcription ability of the promoter (the sequence is shown as SEQ ID NO. 12) is improved by about 7 times than the original ability, so that the promoter P is addedspoiia(cs-1,3)Used for enhancing the expression of key genes in the synthesis pathway of heptaene menadione.
(2) Obtaining of Down regulated promoters
Promoter P to be downregulated by Spo0A-PabrbThe Spo0A-P binding site on the sequence shown in SEQ ID NO.13 is subjected to conservative sequence mutation to obtain 3 promoters P with different transcription capacitiesabrB(OA-2)、PabrB(cs-1)、PabrB(cs-2)And will beThese promoters were fused with the GFP gene (sequence shown in SEQ ID NO.15), and the transcriptional capacities of the different promoters were characterized using the change in fluorescence.
The results show that: as shown in FIG. 3, PabrB(cs-1)(the sequence is shown as SEQ ID NO. 14) the transcription capacity of the promoter is only 18 percent of the original transcription capacity, so that the promoter PabrB(cs-1)The method is used for inhibiting the expression of key genes of a heptaene menadione competition pathway.
Example 7: construction of recombinant bacterium BS19
To increase MK-7 synthesis, P was used on the basis of recombinant strain BS18abrB(cs-1)The recombinant strain BS19 was obtained by in situ replacement of the pyruvate kinase (pyk, genebank ID: 936596) gene and the undecenyl pyrophosphate synthetase (uppS, genebank ID: 939640) gene promoter with promoters that gradually limited the flux of carbon to competing pathways as the cells grew. The final transcript levels of the relevant genes are shown in FIG. 6. The specific construction process is as follows:
(1) cloning of genes
① respectively amplifying to obtain pyk gene upstream homologous arm sequences pyk by using Bacillus subtilis168 genome as templateupPyk gene fragment, artificially synthesized PabrB(cs-1)A promoter sequence (shown as SEQ ID NO. 14) and a lox71-zeo-lox66 box sequence (shown as SEQ ID NO. 2), and then four fragments pykupLox71-zeo-lox66 box, PabrB(cs-1)Overlapping extension PCR is carried out on the promoter sequence and the pyk gene segment to obtain a fusion gene segment pykup-lox71-zeo-lox66-PabrB(cs-1)-pyk。
② respectively amplifying to obtain the upstream homologous arm sequences uppS of uppS gene by taking bacillus subtilis168 genome as a templateupuppS gene fragment, artificially synthesized PabrB(cs-1)A promoter sequence (shown as SEQ ID NO. 14) and a lox71-zeo-lox66 box sequence (shown as SEQ ID NO. 2), and then four fragments of uppSupLox71-zeo-lox66 box, PabrB(cs-1)Overlapping extension PCR is carried out on the promoter sequence and the uppS gene segment to obtain a fusion gene segment uppSup-lox71-zeo-lox66-PabrB(cs-1)-uppS。
(2) Homologous recombination
And (2) transforming the fusion fragment obtained in the step (1) into a BS18 competent cell, coating the competent cell on a bleomycin-resistant LB plate, selecting a single colony growing on the plate, carrying out colony PCR verification and sequencing. Finally knocking out the bleomycin resistance gene zeo in the strain through a Cre/lox recombination system to finally obtain the strain Bacillus subtilis168, P43-menFP43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::lacA Pmena-menA::thrCPmena-menA::dacA Pveg-kinA-ΔPAS-AΔkinB Phag-Rap60(Pnative-Phr60)2::hag PabrB(cs-1)-pyk::pyk PabrB(cs-1)-uppS:: uppS, which is named BS 19.
Example 8: construction of recombinant bacterium BS20
Using a method similar to that of example 7, the recombinant bacterium BS19 obtained in example 7 was supplemented with P obtained in example 6spoiia(cs-1,3)The promoter expresses heptadiallyldiphosphate synthase (HepS/T, genebank ID: 938998) gene and 4-hydroxy-3-methylbut-2-enyldiphosphate reductase (ispH, genebank ID: 937900) gene, resulting in recombinant strain BS20, and allows carbon flux to flow to MK-7 synthesis pathway as the cells grow. The final transcript levels of the relevant genes are shown in FIG. 6.
(1) Obtaining fusion fragments
Respectively amplifying to obtain an upstream homologous arm sequence HepS/T of the HepS/T gene by taking a bacillus subtilis168 genome as a templateupA HepS/T gene fragment, a lox71-zeo-lox66 box sequence (the sequence is shown as SEQ ID NO. 2), and then four fragments of HepS/TupLox71-zeo-lox66 box, Pspoiia(cs-1,3)Performing overlap extension PCR on the promoter sequence and the HepS/T gene segment to obtain a fusion gene segment HepS/Tup-lox71-zeo-lox66-Pspoiia(cs-1,3)-HepS/T。
Respectively amplifying to obtain the upstream homologous arm sequences of the ispH genes by taking the bacillus subtilis168 genome as a templateupispH gene fragment, lox71-zeo-lox66 box sequence (shown as SEQ ID NO. 2), and then the four fragments are subjected to ispHupLox71-zeo-lox66 box, Pspoiia(cs-1,3)Carrying out overlap extension PCR on the promoter sequence and the ispH gene segment to obtain a fusion gene segment ispHup-lox71-zeo-lox66-Pspoiia(cs-1,3)-ispH。
(2) Homologous recombination
And (2) transforming the fusion fragment obtained in the step (1) into a BS19 competent cell, coating the competent cell on a bleomycin-resistant LB plate, selecting a single colony growing on the plate, carrying out colony PCR verification and sequencing. Finally knocking out the bleomycin resistance gene zeo in the strain through a Cre/lox recombination system to finally obtain the strain Bacillus subtilis168, P43-menFP43-menB Phbs-menE P43-entCΔdhbB Phbs-tkt P43-ppsAΔptsG Phbs-aroGfbrP43-aroK Phbs-ispA P43-hepS/T Phbs-kdpG P43-dxr P43-dxs P43-fni Pmena-menA::ganA Pmena-menA::thrCPmena-menA::dacA Pveg-kinA-ΔPAS-AΔkinB Phag-Rap60(Pnative-Phr60)2::hag PabrB(cs-1)-pyk::pyk PabrB(cs-1)-uppS::uppS Pspoiia(cs-1,3)-ispH::ispH Pspoiia(cs-1,3)HepS/T, which is named BS 20.
Example 9: fermentation of the Strain
The seed culture medium formula (mass percent): tryptone 1%, yeast extract 0.5%, sodium chloride 1%.
The formula (mass percent) of the shake flask fermentation medium is as follows: 3-8% of soybean peptone, 3-8% of glucose, 3-8% of sucrose and KH2PO30.06%。
The fermentation medium formula of the fermentation tank (mass percent): soybean peptone 3-8%, glucose 3-8%, caneSugar 3-8%, KH2PO30.06%。
(1) Preparing a seed solution:
the recombinant bacteria BS 1-BS 17, BS19 and BS20 constructed in examples 1, 7 and 8 were inoculated into seed culture media, and cultured at 37 ℃ and 220rpm for 12 hours to obtain a Bacillus subtilis seed solution.
(2) Shake flask fermentation culture
Transferring the seed solution obtained in the step (1) into a 250mL shake flask with the inoculation amount of 5%, wherein the liquid loading amount is 15 mL. The fermentation conditions were 40 ℃ and the fermentation conditions were 220rpm for 6 days, and the fermentation results are shown in FIG. 7, in which the yield of BS19 reached 170mg/L after 6 days of fermentation, the yield of BS20 reached 360mg/L after 6 days of fermentation, and the MK-7 yield was 37.89 times that of Bacillus subtilis 168.
(3) Fermentation culture
Transferring the seed liquid obtained in the step (1) into a fermentation medium with 15% of inoculation amount, fermenting the recombinant strain BS20 by using a 15-L fermentation tank under the fermentation condition of 40 ℃, the tank pressure of 0.05Mpa, the ventilation amount of 10vvm, stirring at 500rpm, and controlling the concentration of glucose at 5g/L by feeding glucose. The fermentation result is shown in FIG. 8, the yield reaches 230mg/L, and the pH of the fermentation liquid at the later stage of fermentation is alkaline.
TABLE 6 fermentation production of MK-7 by recombinant strains
Figure BDA0002086871300000131
Figure BDA0002086871300000141
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
SEQUENCE LISTING
<110> university of south of the Yangtze river
<120> method for synthesizing MK-7 by using Bacillus subtilis group response regulation and control system
<160>37
<170>PatentIn version 3.3
<210>1
<211>846
<212>DNA
<213>Bacillus subtilis 168
<400>1
gcattcatcg tcatatcatc atagctgagc ggagggtttt ccatatcctg cggcgtttgt 60
gagttcccat atttttcgac atcctgatag gaatcctcac tgtcatatgg cgctctgatt 120
tcttcatcat catcaaattc aaattgcccg aatggtgttt cttcttcaat cggacggtct 180
ttggaaacca cgtcctgtga cgaatactcc gcgagggttg tggcagtcgg aagcgcttca 240
agtcgttcga aagggatttc ctttccgctg acttcacaaa tgccatacgt accgttttct 300
atcgccttca atgaatgctc aatgtcccga aggtgctctc tctcatgcaa gtctagagcg 360
atgtctttct cacgctcgta aagttctgtc gcctgatcgc cgggatggtt gtcgtatgcc 420
gaaagctcac cccacgaatc ataaggaaag gctgagttaa gctgaaaatg atcattgtct 480
ttgaaacggt ttaagatatc ttttttcgtt tgttccagtt cattttttaa atgctgaagc 540
tgttctttcg taagcaatgt gatcgcctcg tttctctgtg atgcatacct ttagtatgaa 600
cagatcgcct gagaactttc ataaatggcg ggtggaggaa tataggaggt tttcctttta 660
tggtaagcgg atacaacctt tgctatcagt ggagaaagaa atttaagctt tgtttctttt 720
tcatttctga aattaggttt ataataggta aggcaggcca tttggactgc atgatctgtg 780
tttgacacaa aggagacaca ggtgtatggt attaaaagca ttttaaggat tatggaggaa 840
tgtctc 846
<210>2
<211>588
<212>DNA
<213> Artificial Synthesis
<400>2
gagcggataa caatttcaca caggaaacag ctatgaccat gattacgaat tcgagctcgg 60
tacccgggga tcctctagag ataccgttcg tatagcatac attatacgaa gttatcttga 120
tatggctttt tatatgtgtt actctacata cagaaaggag gaactaaaca tggccaagtt 180
gaccagtgcc gttccggtgc tcaccgcgcg cgacgtcgcc ggagcggtcg agttctggac 240
cgaccggctc gggttctccc gggacttcgt ggaggacgac ttcgccggtg tggtccggga 300
cgacgtgacc ctgttcatca gcgcggtcca ggaccaggtg gtgccggaca acaccctggc 360
ctgggtgtgg gtgcgcggcc tggacgagct gtacgccgag tggtcggagg tcgtgtccac 420
gaacttccgg gacgcctccg ggccggccat gaccgagatc ggcgagcagc cgtgggggcg 480
ggagttcgcc ctgcgcgacc cggccggcaa ctgcgtgcac ttcgtggccg aggagcagga 540
ctgaataact tcgtatagca tacattatac gaacggtaaa tcgtcgac 588
<210>3
<211>300
<212>DNA
<213>Bacillus subtilis 168
<400>3
tgataggtgg tatgttttcg cttgaacttt taaatacagc cattgaacat acggttgatt 60
taataactga caaacatcac cctcttgcta aagcggccaa ggacgctgcc gccggggctg 120
tttgcgtttt tgccgtgatt tcgtgtatca ttggtttact tatttttttg ccaaagctgt 180
aatggctgaa aattcttaca tttattttac atttttagaa atgggcgtga aaaaaagcgc 240
gcgattatgt aaaatataaa gtgatagcgg taccattata ggtaagagag gaatgtacac 300
<210>4
<211>847
<212>DNA
<213>Bacillus subtilis 168
<400>4
atggtgacaa cggtgcagcg tacgttccga aaggaagttc tacatgcatt acataaagcc 60
aaagaagtca accatgctgt cttaataagc tattcgagac aaatcgagtc tcttgaccct 120
ctatcatttt tcaattacgg agcaaaaaaa tatacaggca atcgattttt ttggtcagat 180
cctgaaagtg aattgacaat agtcggtctt ggcaaagaag cggttttcca gacaaatcaa 240
aaaaacagcg agcggtatcg tgaggttttt gaacaatggg agcgctttaa aaagacggct 300
tttcatattt atgaagaaga aaagctgcag cattctgcag tgggacctgt gttattcgga 360
ggattttctt ttgacccttg cgaagaaaga ggttcacaat gggaccattt ctcggaaggg 420
gatttctttg tgcctgcgct tatgctgacg atgactgctg aaggcccgtt cttaacagtt 480
aacagatggg taagcggagg agaagacgca gaagctgttt tagaaggctt aaaagctttt 540
gcggcggaat ttatggttcc cgatttcaag caagaagatc aggctgtgat tgcagcagcc 600
gaagagctgg ataaggatga ttggctgaaa gcaatcgaaa cggccacaag ccaaattaaa 660
gagaaacaat atgataaggt tgttcttgcc cgagagctgc tgctcacgtt tgacggtcca 720
atccaaattg aaccggtgct taaaacgctt ctggacgatc agcagacaag ctatgttttt 780
gcaattgaac aagaaggcaa aacctttgtc ggcgcgtctc cggaaagact gatcaaaaga 840
gacggcg 847
<210>5
<211>328
<212>DNA
<213>Bacillus subtilis 168
<400>5
cttaataatg gaaaaggatc aaggaatagg atgaaaaaag gaaaaaaagg aatattcgtt 60
cggtaaatca ccttaaatcc ttgacgagca agggattgac gctttaaaat gcttgatatg 120
gctttttata tgtgttactc tacatacaga aattcttcac tttgttggac aaacattcct 180
cagagtgcag tttttcttaa aaagccgttt aattgtcttt ctcttacttg ctctcatttt 240
tttctgagac aggtttagaa tcagactgaa ctgtgaagaa atgataataa acgaactgaa 300
tgtatccttt tgggaggagg tgaaaggc 328
<210>6
<211>1053
<212>DNA
<213> Artificial Synthesis
<400>6
atgaattatc agaacgacga tttacgcatc aaagaaatca aagagttact tcctcctgtc 60
gcattgctgg aaaaattccc cgctactgaa aatgccgcga atacggttgc ccatgcccga 120
aaagcgatcc ataagatcct gaaaggtaat gatgatcgcc tgttggttgt gattggccca 180
tgctcaattc atgatcctgt cgcggcaaaa gagtatgcca ctcgcttgct ggcgctgcgt 240
gaagagctga aagatgagct ggaaatcgta atgcgcgtct attttgaaaa gccgcgtacc 300
acggtgggct ggaaagggct gattaacgat ccgcatatgg ataatagctt ccagatcaac 360
gacggtctgc gtatagcccg taaattgctg cttgatatta acgacagcgg tctgccagcg 420
gcaggtgagt ttctcgatat gatcaccctg caatatctcg ctgacctgat gagctggggc 480
gcaattggcg cacgtaccac cgaatcgcag gtgcaccgcg aactggcatc agggctttct 540
tgtccggtcg gcttcaaaaa tggcaccgac ggtacgatta aagtggctat cgatgccatt 600
aatgccgccg gtgcgccgca ctgcttcctg tccgtaacga aatgggggca ttcggcgatt 660
gtgaatacca gcggtaacgg cgattgccat atcattctgc gcggcggtaa agagcctaac 720
tacagcgcga agcacgttgc tgaagtgaaa gaagggctga acaaagcagg cctgccagca 780
caggtgatga tcgatttcag ccatgctaac tcgtccaaac aattcaaaaa gcagatggat 840
gtttgtgctg acgtttgcca gcagattgcc ggtggcgaaa aggccattat tggcgtgatg 900
gtggaaagcc atctggtgga aggcaatcag agcctcgaga gcggggagcc gctggcctac 960
ggtaagagca tcaccgatgc ctgcatcggc tgggaagata ccgatgctct gttacgtcaa 1020
ctggcgaatg cagtaaaagc gcgtcgcggg taa 1053
<210>7
<211>936
<212>DNA
<213>Bacillus subtilis 168
<400>7
atgaaccaaa caaataaggg tgagggtcag acagcgccgc aaaaagaaag catggggcag 60
atcctttggc agttaacccg tcctcatacg ttaaccgcat cgtttgtgcc tgtgctgctc 120
ggaaccgttt tggcgatgtt ttatgtgaag gttgatctgc tgctgttttt ggctatgctg 180
ttttcttgcc tatggatcca gatcgcgacg aacttattta atgaatacta tgattttaaa 240
cgcggattag atacagcaga atcagtcgga atcggagggg ccattgtacg ccacggaatg 300
aagcctaaaa cgattttgca attagctctt gcctcatacg ggattgccat tttgctcggt 360
gtctatattt gtgccagcag cagctggtgg cttgcgctga tcggccttgt cggcatggcg 420
atcggctacc tgtatacagg cgggccgctg ccgattgcgt acacgccgtt cggtgaatta 480
ttctcaggca tttgcatggg ttcggtgttt gtgctgattt cgtttttcat tcagacagat 540
aagatcaata tgcagagcat tttgatttcc atcccgattg cgattcttgt cggcgcgatt 600
aacctgtcga acaacattcg tgatattgaa gaggacaaaa aaggcggacg caaaacattg 660
gcgattttga tggggcataa gggagctgtt actctgttag ctgcgtcgtt tgccgtcgct 720
tatatctggg ttgtcggctt ggttattacc ggtgccgcaa gcccatggct gtttgtcgtc 780
tttttgagcg tgcctaagcc ggttcaggca gtgaagggct tcgtccagaa cgaaatgccg 840
atgaatatga ttgtcgcaat gaaatcaaca gcccaaacaa atacattttt cggattcctg 900
ctctcgatcg gattattgat cagctatttc cgataa 936
<210>8
<211>1537
<212>DNA
<213>Bacillus subtilis 168
<400>8
cttgacagcg ggtttttcat acagctgttt cattaattgc agcatatcaa aaattccctt 60
cccgtttttt cgacaatcac atgattattt gacgatcaga tgctcaaaaa gtttcatttt 120
ttccctaatc tccctcaaat taatatatcg gcgtatgttt ttgaaaatga atctttatac 180
ctgcaagggc aagaatggaa tgtttcgagc tgattcataa taaaggaaaa gatacctgga 240
gtcaaaagat ctttttaact tttaaaaagt gtaatgtact taaaaaaatt tttctgtacc 300
tgttcgttca agtgaaagca gaaacctaat gaaatcaggg cgagaagcgt ataataagaa 360
agaaaacgcc ttcttgcggt atcttgtgaa ataagggaga agtcattatg atagataagg 420
aagcaaaagg agttttttat taagctgccg gctgaaaaaa agtaagcctt ttaatagaaa 480
ggaagaggaa gatgaaccaa acaaataagg gtgagggtca gacagcgccg caaaaagaaa 540
gcatggggca gatcctttgg cagttaaccc gtcctcatac gttaaccgca tcgtttgtgc 600
ctgtgctgct cggaaccgtt ttggcgatgt tttatgtgaa ggttgatctg ctgctgtttt 660
tggctatgct gttttcttgc ctatggatcc agatcgcgac gaacttattt aatgaatact 720
atgattttaa acgcggatta gatacagcag aatcagtcgg aatcggaggg gccattgtac 780
gccacggaat gaagcctaaa acgattttgc aattagctct tgcctcatac gggattgcca 840
ttttgctcgg tgtctatatt tgtgccagca gcagctggtg gcttgcgctg atcggccttg 900
tcggcatggc gatcggctac ctgtatacag gcgggccgct gccgattgcg tacacgccgt 960
tcggtgaatt attctcaggc atttgcatgg gttcggtgtt tgtgctgatt tcgtttttca 1020
ttcagacaga taagatcaat atgcagagca ttttgatttc catcccgatt gcgattcttg 1080
tcggcgcgat taacctgtcg aacaacattc gtgatattga agaggacaaa aaaggcggac 1140
gcaaaacatt ggcgattttg atggggcata agggagctgt tactctgtta gctgcgtcgt 1200
ttgccgtcgc ttatatctgg gttgtcggct tggttattac cggtgccgca agcccatggc 1260
tgtttgtcgt ctttttgagc gtgcctaagc cggttcaggc agtgaagggc ttcgtccaga 1320
acgaaatgcc gatgaatatg attgtcgcaa tgaaatcaac agcccaaaca aatacatttt 1380
tcggattcct gctctcgatc ggattattga tcagctattt ccgataataa aaaagaccgc 1440
tcgtttcatg cggtcttttt ttgttacaat cgaccgcatt ttgtaaaaaa attcatagaa 1500
ccttgcagca gacagggacg tctagtacat ggacagc 1537
<210>9
<211>1490
<212>DNA
<213> Artificial Synthesis
<400>9
tggaacagga tgaagaagaa acaggccatc aatccctaaa ctgcgaaaaa catgaaatcg 60
aacctgcaag cccggaatcg actacatata taacggatga ttatgaacgg ttggttgaaa 120
atctcccgag tccgctatgc atcagtgtca aaggcaagat cgtctatgta aacagcgcga 180
tgctttcaat gctgggagcc aaaagcaagg atgctattat tggtaaatcg tcctatgaat 240
ttattgaaga agaatatcat gatatcgtga aaaacaggat tatacgaatg caaaaaggaa 300
tggaagtcgg aatgattgaa cagacgtgga aaaggcttga tggcacacct gttcatttag 360
aagtgaaagc atccccgacc gtctacaaaa accagcaggc tgagctgctg ctgctgatcg 420
atatctcttc aaggaaaaaa ttccaaacca tcctgcaaaa aagccgtgaa cgatatcagc 480
tgctgattca aaattccatt gataccattg cggtgattca caatggaaaa tgggtattta 540
tgaatgaatc gggaatttcc ctgtttgaag cggctacata tgaggattta attggcaaaa 600
acatatacga tcagctgcat ccttgcgatc acgaggatgt aaaagagaga atccaaaaca 660
ttgccgagca aaaaacagaa tctgaaattg tcaagcaatc ctggttcacc tttcagaaca 720
gggtcatcta tacggagatg gtctgcattc cgacgacctt ttttggtgaa gcggccgtcc 780
aggtcattct tcgggacatc tcagagagaa aacaaacaga agaattgatg ctgaaatcgg 840
aaaaattatc aatcgcaggg cagctcgcgg cgggaatcgc ccatgagatc cgcaaccctc 900
ttacagcgat caaaggattt ttacagctga tgaaaccgac aatggaaggc aacgaacatt 960
actttgatat tgtgttttct gaactcagcc gtatcgaatt aatactcagt gaactgctca 1020
tgctggcgaa acctcagcaa aatgctgtca aagaatattt gaacttgaaa aaattaattg 1080
gtgaggtttc agccctgtta gaaacgcagg cgaatttaaa tggcattttt atcagaacaa 1140
gttatgaaaa agacagcatt tatataaacg gggatcaaaa ccaattaaag caggtattca 1200
ttaatttaat caaaaatgca gttgaatcaa tgcctgatgg gggaacagta gacattatca 1260
taaccgaaga tgagcattct gttcatgtta ctgtcaaaga cgaaggggaa ggtatacctg 1320
aaaaggtact aaaccggatt ggagagccat ttttaacaac aaaagaaaaa ggtacggggc 1380
ttggattaat ggtgacattt aatatcattg aaaaccatca gggagttata catgtggaca 1440
gccatcctga aaaaggcaca gcgtttaaaa tttcatttcc aaaaaaataa 1490
<210>10
<211>320
<212>DNA
<213>Bacillus subtilis 168
<400>10
tatgggaagt gctccgtaat acgctgacaa gagagaaagg gcttggaggt attgaaacaa 60
gaggagttct gagaattggt atgccttata agtccaatta acagttgaaa acctgcatag 120
gagagctatg cgggtttttt attttacata atgatacata atttaccgaa acttgcggaa 180
cataattgag gaatcataga attttgtcaa aataatttta ttgacaacgt cttattaacg 240
ttgatataat ttaaatttta tttgacaaaa atgggctcgt gttgtacaat aaatgtagtg 300
aaaggaggtg aaatgtacac 320
<210>11
<211>574
<212>DNA
<213>Bacillus subtilis 168
<400>11
ctggtgtaga cggcgtaaaa acaggctata caggcgaagc gaaatattgt ctgactgctt 60
cggctaaaaa aggaaacatg cgggccatag cggttgtatt cggagcgagc acgcctaaag 120
aaagaaacgc gcaagtgaca aaaatgcttg acttcgcctt tagccaatat gaaacgcatc 180
ctttatataa acgaaatcaa acagtagcaa aagtaaaggt caaaaaaggg aaacaaaaat 240
ttatcgaact cactacatct gagccgattt caatattgac gaaaaaaggc gaggatatga 300
acgatgtgaa aaaagaaatc aagatgaagg acaatattag tgctccgatt caaaaaggcc 360
aagagcttgg cactcttgtt ctgaaaaagg atggagaagt actcgctgaa agtcctgttg 420
ctgcaaaaga agatatgaag aaagccgggt ttatcacatt cttaaagcgg acgatgggag 480
actggacaaa atttaagtaa ttatgaccac tagtttgtga aggaattcat tcatcgaaac 540
actcattatc cgatcatatc aaggaggaat gagc 574
<210>12
<211>603
<212>DNA
<213> Artificial Synthesis
<400>12
ctggtgtaga cggcgtaaaa acaggctata caggcgaagc gaaatattgt ctgactgctt 60
cggctaaaaa aggaaacatg cgggccatag cggttgtatt cggagcgagc acgcctaaag 120
aaagaaacgc gcaagtgaca aaaatgcttg acttcgcctt tagccaatat gaaacgcatc 180
ctttatataa acgaaatcaa acagtagcaa aagtaaaggt caaaaaaggg aaacaaaaat 240
ttatcgaact cactacatct gagccgattt caatattgac gaaaaaaggc gaggatatga 300
acgatgtgaa aaaagaaatc aagatgaagg acaatattag tgctccgatt caaaaaggcc 360
aagagcttgg cactcttgtt ctgaaaaagg atggagaagt actcgctgaa agtcctgttg 420
ctgcaaaaga agatatgaag aaagccgggt ttatcacatt cttaaagcgg acgatgggag 480
actggacaaa atttaagtaa ttatttgtcg aaaatgacca ctagttttgt cacggtgaag 540
gaattcattc tttgtcgaaa aatcgaaaca ctcattatcc gatcatatca aggaggaatg 600
agc 603
<210>13
<211>580
<212>DNA
<213>Bacillus subtilis 168
<400>13
catctcctgc gactgtcgta tatgcatggc cgatatgtaa ttttccgctc ggataataaa 60
tcggtgttgt aatgtaaaat gtattgtttt cttgcggcat cttgaaacct cctaatcaga 120
atgtcaaaaa gctcccgccc aaaggacgag agcggcgata agtgcaaatc atatatgaat 180
attatttata tttatccttt atctatgata ccatcttagc ctttaagatc aagaatatat 240
acatacgccc tgaaaaagaa taattaaaat taaaaatctt taatgaaaat aaaaaaagtc 300
tgttcgtgtc gaattttgtc gtatataatc aaatgaaata aaaaactttg gttcgaaagt 360
cttgatttaa aaggattttt agtaggataa tagctttatt aaatatttat aaaatgctgt 420
tatttcggta gtttccaaga cattactgac tataagaact aattcttaca atcaatagta 480
aacaaaatga ttgacgatta ttggaaacct tgttatgcta tgaaggtaag gattttaaga 540
aaaatataat ttaaacaaat aagtatctct tgggaggaga 580
<210>14
<211>601
<212>DNA
<213> Artificial Synthesis
<400>14
catctcctgc gactgtcgta tatgcatggc cgatatgtaa ttttccgctc ggataataaa 60
tcggtgttgt aatgtaaaat gtattgtttt cttgcggcat cttgaaacct cctaatcaga 120
atgtcaaaaa gctcccgccc aaaggacgag agcggcgata agtgcaaatc atatatgaat 180
attatttata tttatccttt atctatgata ccatcttagc ctttaagatc aagaatatat 240
acatacgccc tgaaaaagaa taattaaaat taaaaatctt taatgaaaat aaaaaaagtc 300
tgttcgtgtc gaattttgtc gtatataatc aaatgaaata aaaaactttg gttcgaaagt 360
cttgatttaa aaggattttt agtaggataa tagctttatt aaatatttat aaaatgctgt 420
tatttcggta gtttccaaga cattactgac tataagaact aattcttaca atcaatagta 480
aacaaaatga ttgacgatta ttggaaacct tgttatgcta tgaaggtaag gattttttgt 540
cgaaaataat ttgtcgaaag aaaaatataa tttaaacaaa taagtatctc ttgggaggag 600
a 601
<210>15
<211>717
<212>DNA
<213> Artificial Synthesis
<400>15
atgggtaagg gagaagaact tttcactgga gttgtcccaa ttcttgttga attagatggt 60
gatgttaatg ggcacaaatt ttctgtcagt ggagagggtg aaggtgatgc aacatacgga 120
aaacttaccc ttaaatttat ttgcactact ggaaagctgc ctgttccttg gccaacactt 180
gtcactactc ttacttatgg tgttcaatgc ttttcaagat acccagatca tatgaagcgg 240
cacgacttct tcaagagcgc catgcctgag ggatacgtgc aggagaggac catcttcttc 300
aaggacgacg ggaactacaa gacacgtgct gaagtcaagt ttgagggaga caccctcgtc 360
aacagaatcg agcttaaggg aatcgatttc aaggaggacg gaaacatcct cggccacaag 420
ttggaataca actacaactc ccacaacgta tacatcatgg cagacaaaca aaagaatgga 480
atcaaagtta acttcaaaat tagacacaac attgaagatg gaagcgttca actagcagac 540
cattatcaac aaaatactcc aattggcgat ggccctgtcc ttttaccaga caaccattac 600
ctgtccacac aatctgccct ttcgaaagat cccaacgaaa agagagacca catggtcctt 660
cttgagtttg taacagctgc tgggattaca catggcatgg atgaactgta caaataa 717
<210>16
<211>564
<212>DNA
<213> Artificial Synthesis
<400>16
aactgctgaa cttttggata tcgataatat tcaagacgta gaagtcatga caatattgac 60
tatggcagag ccatttgaaa agtctactgc gaatttattg gctcccatta ttgtgaatcg 120
caagaacatg atggctaagc aagtcgtttt acacgactcc tcatatacga caaagcatcc 180
gattggagga gaatcatgct agttttatcg cggaaaataa acgaagcgat tcaaataggt 240
gctgatattg aagtaaaagt gattgcggtt gaaggggatc aagtgaagct tggaattgac 300
gccccaaagc atattgatat tcacaggaaa gaaatttact tgaccattca ggaagaaaat 360
aaccgtgcag cagcgttatc cagcgatgtg atctccgcat tatcctcaca aaaaaagtga 420
ggattttttt atttttgtat taacaaaatc agagacaatc cgatattaat gatgtagccg 480
ggaggaggcg caaaagactc agccagttac aaaataaggg cacaaggacg tgccttaaca 540
acatattcag ggaggaacaa aaca 564
<210>17
<211>396
<212>DNA
<213>Bacillus subtilis 168
<400>17
gctttttcgg aaaagcaatg gaacaggcgg aagaatttaa cgattctctg tttcaagatc 60
tgcttaacgt tctgaaagcc ctgtttatcg aaacaggctc aagacagaaa gtgatgaacg 120
ctcttgaagc cttacgcaca ggccaaggat acccgtactt tgaagaactt gcactgatcg 180
ctgccgaatt ttatacaatg gataaacgca tggaagattc aatctacttt tacaacgaaa 240
tggtttgtgc gcaaagacag atccaacgcg gagattttct gtatgaagtt taaaggctta 300
ttttctgctg tcctgattgt ttcactgctt gtgggcgcag gatactcatt tgttcatcat 360
gatgaagttt cagtggcaag cagaaatgcg acataa 396
<210>18
<211>30
<212>DNA
<213> Artificial Synthesis
<400>18
gcattcatcg tcatatcatc atagctgagc 30
<210>19
<211>59
<212>DNA
<213> Artificial Synthesis
<400>19
tgtgaaattg ttatccgctc gagacattcc tccataatcc ttaaaatgct tttaatacc 59
<210>20
<211>27
<212>DNA
<213> Artificial Synthesis
<400>20
tgataggtgg tatgttttcg cttgaac 27
<210>21
<211>28
<212>DNA
<213> Artificial Synthesis
<400>21
gtgtacattc ctctcttacc tataatgg 28
<210>22
<211>53
<212>DNA
<213> Artificial Synthesis
<400>22
tttaaggatt atggaggaat gtctcgagcg gataacaatt tcacacagga aac 53
<210>23
<211>30
<212>DNA
<213> Artificial Synthesis
<400>23
aatcatacct accacaatat catgctcaag 30
<210>24
<211>22
<212>DNA
<213> Artificial Synthesis
<400>24
ttccatatcc tgcggcgttt gt 22
<210>25
<211>25
<212>DNA
<213> Artificial Synthesis
<400>25
acgaagttat tcagtcctgc tcctc 25
<210>26
<211>25
<212>DNA
<213> Artificial Synthesis
<400>26
cttgacagcg ggtttttcat acagc 25
<210>27
<211>23
<212>DNA
<213> Artificial Synthesis
<400>27
gctgtccatg tactagacgt ccc 23
<210>28
<211>19
<212>DNA
<213> Artificial Synthesis
<400>28
actggcttgg acggtggtt 19
<210>29
<211>47
<212>DNA
<213> Artificial Synthesis
<400>29
gtatgaaaaa cccgctgtca agtcctcctt gttctcttag cccttcg 47
<210>30
<211>39
<212>DNA
<213> Artificial Synthesis
<400>30
ctgggaaaac cctggcggct gatgctccgc tcgatatgg 39
<210>31
<211>20
<212>DNA
<213> Artificial Synthesis
<400>31
cgccaatcgc tgacctgaag 20
<210>32
<211>24
<212>DNA
<213> Artificial Synthesis
<400>32
ctggtgtaga cggcgtaaaa acag 24
<210>33
<211>32
<212>DNA
<213> Artificial Synthesis
<400>33
gctcattcct ccttgatatg atcggataat ga 32
<210>34
<211>41
<212>DNA
<213> Artificial Synthesis
<400>34
tatcaaggag gaatgagcat gggtaaggga gaagaacttt t 41
<210>35
<211>42
<212>DNA
<213> Artificial Synthesis
<400>35
ccaagcttct gcagttattt gtacagttca tccatgccat gt 42
<210>36
<211>36
<212>DNA
<213> Artificial Synthesis
<400>36
ctgtacaaat aactgcagaa gcttggcgta atcatg 36
<210>37
<211>44
<212>DNA
<213> Artificial Synthesis
<400>37
gccgtctaca ccagttgctc aaaaaaatct cggtcagatg ttac 44

Claims (10)

1. A method for synthesizing MK-7 by using a Bacillus subtilis group response regulation and control system is characterized in that the following modification is carried out on the chromosome of the Bacillus subtilis:
(1) carrying out truncation mutation on the gene of the histidine kinase KinA, carrying out constitutive expression, and knocking out the gene of the histidine kinase KinB; the truncation mutation refers to the knocking out of A PAS-A region of A signal conduction part of A histidine kinase KinA gene, and the sequence of the knocked-out histidine kinase KinA gene kinA-deltA PAS-A is shown in SEQ ID NO. 9;
(2) will contain PhagThe Rap60 gene of the promoter is integrated on a chromosome, and two copies of the expression frame of the signal molecule Phr60 are integrated on the chromosome at the downstream of the Rap60 gene;
(3) using PabrB(cs-1)The promoter replaces the promoters of the pyruvate kinase gene and the undecenyl pyrophosphate synthetase gene; the P isabrB(cs-1)The sequence of the promoter is shown in SEQ ID NO. 14.
2. The method according to claim 1, wherein the genebank ID of the histidine kinase KinA in step (1) is 939230; the genebank ID of the histidine kinase KinB is 937167.
3. The method of claim 1, wherein said P in step (2)hagThe promoter sequence is shown in SEQ ID NO. 16; the genebank ID of the transcription factor Rap60 is 1115983; the sequence of the expression cassette of the signal molecule Phr60 is shown in SEQ ID NO. 17.
4. The method according to claim 1, wherein the pyruvate kinase gene pyk in step (3) has a genebank ID of 936596; the genebank ID of the undecenyl pyrophosphate synthetase gene uppS is 939640.
5. The method of claim 1, further comprising using Pspoiia(cs-1,3)The promoter expresses hepta-diallyl diphosphate synthase gene and 4-hydroxy-3-methylbut-2-enyl diphosphate reductase gene; the P isspoiia(cs-1,3)The sequence of the promoter is shown in SEQ ID NO. 12.
6. A recombinant bacterium for producing heptaene menadione is characterized in that the chromosome of Bacillus subtilis is modified as follows:
(1) carrying out truncation mutation on the gene of the histidine kinase KinA, carrying out constitutive expression, and knocking out the gene of the histidine kinase KinB; the truncation mutation refers to the knocking out of A PAS-A region of A signal conduction part of A histidine kinase KinA gene, and the sequence of the knocked-out histidine kinase KinA gene kinA-deltA PAS-A is shown in SEQ ID NO. 9;
(2) will contain PhagThe Rap60 gene of the promoter is integrated on a chromosome, and two copies of the expression frame of the signal molecule Phr60 are integrated on the chromosome at the downstream of the Rap60 gene;
(3) using PabrB(cs-1)The promoter replaces the promoters of the pyruvate kinase gene and the undecenyl pyrophosphate synthetase gene; the P isabrB(cs-1)The sequence of the promoter is shown in SEQ ID NO. 14.
7. The recombinant bacterium according to claim 6, wherein the genebank ID of the histidine kinase KinA in step (1) is 939230; the genebank ID of the histidine kinase KinB is 937167.
8. The recombinant bacterium according to claim 6, wherein P in step (2) ishagThe promoter sequence is shown in SEQ ID NO. 16; the genebank ID of the transcription factor Rap60 is 1115983; the expression cassette of the signal molecule Phr60The sequence is shown as SEQ ID NO. 17.
9. The recombinant bacterium according to claim 6, wherein the genebank ID of the pyruvate kinase gene pyk in step (3) is 936596; the genebank ID of the undecenyl pyrophosphate synthetase gene uppS is 939640.
10. The recombinant bacterium according to claim 6, wherein the recombinant bacterium is modified as follows based on claim 6: using Pspoiia(cs-1,3)The promoter expresses hepta-diallyl diphosphate synthase gene and 4-hydroxy-3-methylbut-2-enyl diphosphate reductase gene; the P isspoiia(cs-1,3)The sequence of the promoter is shown in SEQ ID NO. 12.
CN201910490611.1A 2019-06-06 2019-06-06 Method for synthesizing MK-7 by using bacillus subtilis group response regulation and control system Active CN110157749B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910490611.1A CN110157749B (en) 2019-06-06 2019-06-06 Method for synthesizing MK-7 by using bacillus subtilis group response regulation and control system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910490611.1A CN110157749B (en) 2019-06-06 2019-06-06 Method for synthesizing MK-7 by using bacillus subtilis group response regulation and control system

Publications (2)

Publication Number Publication Date
CN110157749A CN110157749A (en) 2019-08-23
CN110157749B true CN110157749B (en) 2020-10-09

Family

ID=67627727

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910490611.1A Active CN110157749B (en) 2019-06-06 2019-06-06 Method for synthesizing MK-7 by using bacillus subtilis group response regulation and control system

Country Status (1)

Country Link
CN (1) CN110157749B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110229772B (en) * 2019-06-04 2021-05-28 南通励成生物工程有限公司 Recombinant bacillus subtilis for increasing yield of hepta-menadione and application thereof
CN112852691B (en) * 2019-11-28 2022-09-16 中国科学院微生物研究所 Recombinant escherichia coli producing MK-7 and construction method and application thereof
CN111549045B (en) * 2020-01-17 2023-09-19 西宝生物科技(上海)股份有限公司 Vitamin K improvement by utilizing recombinant bacillus natto 2 Method for producing yield
US20230212593A1 (en) * 2020-03-04 2023-07-06 Basf Se Method for the production of constitutive bacterial promoters conferring low to medium expression
CN111471634A (en) * 2020-03-14 2020-07-31 天津大学青岛海洋技术研究院 Method for genetically modifying bacillus subtilis, strain obtained by method and application of strain
CN112481278B (en) * 2020-12-09 2023-02-21 江南大学 Biosensor based on AIP induction and application thereof
CN114350699B (en) * 2021-12-02 2024-03-26 江南大学 Strain for producing D-psicose 3-epimerase and application thereof
CN116064633B (en) * 2022-11-03 2024-06-11 安徽工程大学 Construction of efficient biosynthesis of vitamin K2Engineering bacteria method
CN116286574B (en) * 2023-02-09 2023-12-12 中国农业大学 CRISPRa method for accurately regulating Bacillus subtilis endogenous polygene expression and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002034554A (en) * 2000-07-28 2002-02-05 Mitsukan Group Honsha:Kk Bacillus natto producing vitamin k at high concentration, method for breeding the same and fermented soybean
CN106222190B (en) * 2016-08-25 2019-10-25 江南大学 A kind of bacillus subtilis logarithmic phase expression system
CN107058316A (en) * 2016-12-09 2017-08-18 江南大学 A kind of bacillus subtilis self-induction expression system and its application
KR101888072B1 (en) * 2016-12-27 2018-08-14 민병규 Novel Bacillus subtilis BSM-KO2 having improved menaquinone-7 productivity and method for mass production of menaquinone-7 by using thereof
CN108715825B (en) * 2018-06-01 2021-03-09 天津大学 Gene overexpression, strain obtained by gene overexpression and application of gene overexpression

Also Published As

Publication number Publication date
CN110157749A (en) 2019-08-23

Similar Documents

Publication Publication Date Title
CN110157749B (en) Method for synthesizing MK-7 by using bacillus subtilis group response regulation and control system
CN110229772B (en) Recombinant bacillus subtilis for increasing yield of hepta-menadione and application thereof
CN110229841B (en) Method for increasing copy number of gene menA and improving MK-7 yield
US20190309336A1 (en) Improved process for the production of fucosylated oligosaccharides
KR101937682B1 (en) Recombinant strain producing l-amino acids, constructing method therefor and method for producing l-amino acids
DK2443163T3 (en) POLYMERIZATION OF ISOPREN FROM RENEWABLE RESOURCES
DK2217711T3 (en) Production of isoprenoids
KR20110122672A (en) Methods of producing isoprene and a co-product
KR20110038087A (en) Polymers of isoprene from renewable resources
CN113366009A (en) Bi-directional multienzyme scaffold for biosynthesis of cannabinoids
TW201111512A (en) Improved isoprene production using the DXP and MVA pathway
CN111321087A (en) Yarrowia lipolytica gene engineering bacterium for producing β -carotene and application thereof
CN108676766B (en) Application of gene modification and strain obtained by using same
CN113549588B (en) Genetically engineered bacterium for producing 5-hydroxytryptophan and construction method and application thereof
CN110982721B (en) Method for improving yield of saccharomyces cerevisiae metabolites
CN112877270A (en) Genetic engineering bacterium for producing hydroxyl tetrahydropyrimidine and application thereof
CN114958627A (en) Construction method and application of recombinant schizochytrium limacinum engineering bacterium for high yield of tocopherol
Min et al. Phase determination of circadian gene expression in Synechococcus elongatus PCC 7942
CN109136119B (en) Microorganisms and uses thereof
CN114317384A (en) Recombinant bacillus subtilis for producing 2&#39; -fucosyllactose and construction method and application thereof
CN108588106B (en) Lycopene high-yield strain, preparation method and application thereof
CN113684163B (en) Genetically engineered bacterium for improving lactoyl-N-tetraose yield and production method thereof
CN113957027B (en) Genetically engineered bacterium for improving lactoyl-N-fucose yield and production method thereof
CN109136120B (en) Microorganisms and uses thereof
CN111548946B (en) Recombinant yeast engineering bacterium for producing sub-tanshinone diene

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Liu Long

Inventor after: Cui Shixiu

Inventor after: Lv Xueqin

Inventor after: Li Jianghua

Inventor after: Du Guocheng

Inventor after: Chen Jian

Inventor before: Liu Long

Inventor before: Cui Shixiu

Inventor before: Lv Xueqin

Inventor before: Li Jianghua

Inventor before: Du Guocheng

Inventor before: Chen Jian

CB03 Change of inventor or designer information
GR01 Patent grant
GR01 Patent grant